M-A: Adjuvant chemotherapy for muscle-invasive bladder cancer.

Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials – European Urology

Commentary on Twitter

Adjuvant Chemotherapy for MIBC: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trialshttps://t.co/EZzsMirWAz

"Cisplatin-based adjuvant chemotherapy is a valid option for improving outcomes for muscle-invasive bladder cancer" pic.twitter.com/dIB1aqqNHn

— European Urology (@EUplatinum) November 26, 2021